Leuprolide

This page contains recent news articles, when available, and an overview of Leuprolide but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Leuprolide
(when available)

Pharmacology and use:
Used in the palliative treatment of advanced prostate cancer. Leuprolide is a luteinizing hormone agonist that results in suppression of testicular or follicular steroidogenesis. For treatment of prostate cancer, endometriosis, uterine fibroids and premature puberty

Mechanism Of Action:
Leuprolide binds to the gonadotropin releasing hormone receptor and acts as a potent inhibitor of gonadotropin secretion.

News Articles on Leuprolide

Bioencapsulation Technology  -  ‎Dec 16, 2009‎
The first two drugs under development using the Q-Sphera delivery system are the biosimilars, Q-Leuprolide (primary indications in prostate cancer and ... Drug Discovery & Development

Ferring unveils positive trial outcome for FIRMAGON  -  ‎Dec 23, 2009‎
FIRMAGON have a significantly lower chance of prostate-specific-antigen (PSA) recurrence compared with those taking existing treatment leuprolide. ... Zenopa

Commercial Insight: Antihormonal Cancer Therapies - New Report Published  -  ‎Jan 3, 2010‎
In 2008, Arimidex (anastrozole; AstraZeneca), Lupron (leuprolide; Takeda/Abbott) and Casodex (bicalutamide; AstraZeneca) were the three leading antihormonal ... OfficialWire (press release)

Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM ...  -  ‎Dec 28, 2009‎
Additionally, Soligenix has a Lipid Polymer Micelle (LPM(TM)) drug delivery technology for the oral delivery of leuprolide for the treatment of prostate ... PR Newswire (press release)

Firmagon(R) has a Significantly Greater Probability of PSA Recurrence-Free ...  -  ‎Dec 21, 2009‎
PSA recurrence was more frequent with leuprolide (12.9%) than with degarelix 240/80 mg (7.7%) during the first year. Among patients who had elevated PSA ... PR Newswire UK (press release)

Prostate cancer treatment linked to greater risk of heart disease and diabetes  -  ‎Dec 11, 2009‎
These drugs, which are injected by a physician or implanted under the skin every few months, include leuprolide (brand name Lupron) and goserelin (Zoladex). ... Globe and Mail

Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the ...  -  ‎Dec 21, 2009‎
Additionally, Soligenix has a Lipid Polymer Micelle (LPMâ„¢) drug delivery technology for the oral delivery of leuprolide for the treatment of prostate cancer ... CNNMoney.com (press release)

Firmagon presenta una probabilidad mayor de supervivencia libre PSA que leuprolide  -  ‎Dec 21, 2009‎
La recurrencia PSA fue más frecuente con leuprolide (12,9%) que con degarelix 240/80 mg (7,7%) durante el primer año. Entre los pacientes con elevados ... Finanzas.com

Firmagon(R) présente une probabilité significativement plus importante de ...  -  ‎Dec 22, 2009‎
Par ailleurs, cette suppression S-ALP avec Firmagon a été soutenue tout au long de l'étude, à la différence de leuprolide avec lequel une hausse ... Capital.fr

Firmagon® erhöht verglichen mit Leuprorelin die Wahrscheinlichkeit eines PSA ...  -  ‎Dec 22, 2009‎
Additional anaylsis of the secondary end point of biochemical recurrence rate in a Phase III trial (CS21) comparing degarelix 80mg versus Leuprolide in ... PresseEcho.de (Pressemitteilung)

Tennesseans let cancer kill them  -  14 Nov 2009
After cryogenic surgery, or the freezing of cancer cells; taking the testosterone reducer leuprolide acetate; and changing his lifestyle, blood tests to ... The Tennessean

Beyond the Abstract - Degarelix: A new approach for the treatment of prostate ...  -  ‎Nov 5, 2009‎
5 Patients received either degarelix 240 mg for 1 month, followed by monthly maintenance doses of 80 or 160 mg, or monthly doses of leuprolide 7.5 mg. ... UroToday

Endometriosis could be the cause of pain, infertility  -  ‎Nov 12, 2009‎
Drugs like Lupron (leuprolide), Zoladex (goserelin) and Synarel (nafarelin) suppress ovarian release of estrogen and cause the endometrial transplants to ... Herald & Review

Soligenix Reports Third Quarter 2009 Financial Results  -  ‎Nov 13, 2009‎
Additionally, Soligenix has a Lipid Polymer Micelle (LPM(TM)) drug delivery technology for the oral delivery of leuprolide for the treatment of prostate ... PR Newswire (press release)

Bullish Technical Breakout Alert (OTC:SNGX.OB)  -  ‎Nov 11, 2009‎
Additionally, Soligenix has a Lipid Polymer Micelle (LPM(TM)) drug delivery technology for the oral delivery of leuprolide for the treatment of prostate ... OfficialWire (press release)

ASTRO: Hormones Plus Radiation Ups Survival in Prostate Cancer  -  ‎Nov 3, 2009‎
The androgen deprivation regimen consisted of flutamide plus goserelin or leuprolide. In both treatment arms, patients received a total radiation dose of 66 ... MedPage Today

Neurocrine Biosciences Reports Third Quarter 2009 Results  -  ‎Oct 28, 2009‎
...double-blind, placebo and active controlled trial with four treatment arms; elagolix 150 mg, elagolix 250 mg, leuprolide depot, and placebo. ... Reuters

Soligenix to Present at 8th Annual BIO Investor Forum  -  ‎Oct 27, 2009‎
Additionally, Soligenix has a Lipid Polymer Micelle (LPM(TM)) drug delivery technology for the oral delivery of leuprolide for the treatment of prostate ... SunHerald.com (press release)

QLT Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new ...  -  ‎Nov 13, 2009‎
The Eligard product line includes one, three, four and six month commercial formulations of Atrigel technology combined with leuprolide acetate. ... PR-inside.com (press release)

Commercial Insight: Antihormonal Cancer Therapies - Stagnant sales indicative ...  -  ‎Oct 30, 2009‎
In 2008, Arimidex (anastrozole; AstraZeneca), Lupron (leuprolide; Takeda/Abbott) and Casodex (bicalutamide; AstraZeneca) were the three leading antihormonal ... PRMinds (press release)

전립선암 치료제 시장 '확대ì?¼ë¡œ'  -  ‎Nov 11, 2009‎
...goserelin), '카소ë?±ìФ'(Casodex, bicalutamide), '루프론'(Lupron, euprolide), '엘리가드'(Eligard, leuprolide) 등 호르몬 치료제가 주류를 ì?´ë£¨ê³  있다. ... 디지틀보사

Leuprolide Acetate Stabilizes Cognitive and Functional Decline in …  -  May 16, 2006
RALEIGH, NC, May 16 /PRNewswire/ -- Leuprolide acetate, when used in conjunction with standard Alzheimer's therapy, was shown to stabilize the cognitive and ... Free with registration - PR Newswire - AccessMyLibrary.com

Leuprolide (Systemic).  -  Jul 28, 2005
Leuprolide (loo-PROE-lide) may be used for a number of different medical problems. These include treatment of:. anemia caused by bleeding of uterine ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

FDA Approves Ferring Pharmaceuticals' Degarelix (Generic Name) For …  -  Dec 31, 2008
Degarelix was at least as effective as leuprolide in achieving and maintaining ... In that same time period, none of the patients who received leuprolide ... Medical News Today - Medical News Today (press release)

How to take Leuprolide from Consumer Reports Health.  -  Jan 4, 2006
...tell your doctor and pharmacist if you are allergic to leuprolide; any of the ingredients in leuprolide injection or implant; other gonadotropin-releasing ... consumerreports.org

… Launches Initiation Of Clinical Development Program For Oral Leupro...  -  Apr 4, 2007
The LPMâ„¢ system is a platform technology designed to allow for the oral administration of drugs such as leuprolide that are water-soluble but poorly ... webwire.com

Leuprolide Acetate Maintains Functional Capabilities In Women With …  -  Jul 18, 2006
MADRID - Women with mild to moderate Alzheimer's disease who are treated with the investigational hormone drug leuprolide acetate and conventional therapy ... Medical News Today - Medical News Today (press release)

LEUPROLIDE (Intramuscular route, Subcutaneous route, Intradermal …  -  May 1, 2007
Leuprolide may be used for a number of different medical problems. These include treatment of:. Leuprolide is similar to a hormone normally released from ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Skin patch for Alzheimer's improves quality of life; better options...  -  Jul 24, 2006
Doctors noticed some men with both Alzheimer's and prostate cancer seemed to fare better cognitively while taking leuprolide. If the effect was real, ... Pay-Per-View - The Record - ProQuest Archiver

… Disease; Trial enrollment completed for DURIN-based leuprolide...  -  Feb 28, 2005
Voyager Pharmaceutical owns a broad-based patent covering the use of leuprolide acetate and other compounds for the treatment of Alzheimer disease. ... Pay-Per-View - Mental Health Weekly Digest - Factiva, from Dow Jones

… PSA and Testosterone Levels Faster Than Leuprolide in Prostate...  -  May 23, 2008
A third group of 201 men were randomised to monthly leuprolide 7.5 mg depot ... None of the patients on leuprolide reached this goal by day 3 (P < .001). ... DG News

Ranbaxy unveils 2 urology products  -  Jan 30, 2007
...mg and 45 mg (Leuprolide Depot) that has been in-licensed from QLT Inc, USA — have been launched in the domestic market, the company said in a release. ... Hindu Business Line

Learn about Leuprolide from Consumer Reports Health.  -  Jan 4, 2006
Your doctor has ordered the drug leuprolide to help treat your illness. Leuprolide comes as a solution (Lupron) that is injected subcutaneously (just under ... consumerreports.org

Prostate cancer drug reduces testosterone levels in as little as 3...  -  Dec 3, 2008
In contrast, median testosterone levels in the leuprolide group had increased by 65 per cent by ... The figure for the leuprolide group was 96.4 per cent. ... Eureka! Science News

DOR's oral leuprolide to start trials mid-year  -  Apr 11, 2007
By Peter Mansell, 11-Apr-2007. US company DOR BioPharma plans to start clinical trials in the next few months with what could be the first oral formulation ... In-PharmaTechnologist.com

Paraphilia; Leuprolide acetate may be effective treatment for...  -  Jan 18, 2005
2005 JAN 18 - (NewsRx.com & NewsRx.net) -- Study results suggest that leuprolide acetate may be an effective treatment for young adult patients with ... Pay-Per-View - Science Letter - Factiva, from Dow Jones

Leuprolide Acetate Stabilises Cognitive Decline in Women With …  -  Apr 24, 2006
By Chris Berrie. GENEVA, SWITZERLAND -- April 24, 2006 -- Leuprolide acetate, a drug that is commonly used to treat prostate cancer, appears to produce a ... DG News

Taking Leuprolide from Consumer Reports Health.  -  Jan 4, 2006
Leuprolide may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:. Some side effects can be serious. ... consumerreports.org

Paraphilia; Leuprolide acetate may be effective treatment for...  -  Jan 21, 2005
2005 JAN 21 - (NewsRx.com & NewsRx.net) -- Study results suggest that leuprolide acetate may be an effective treatment for young adult patients with ... Pay-Per-View - Drug Week - Factiva, from Dow Jones

Implant slows symptoms of Alzheimer's  -  Jul 25, 2006
Each implant contains a medicine called leuprolide acetate, which has been used for over 20 years to treat prostate cancer. Now new research suggests it ... Daily Mail

Sanofi-Aventis Announces Commercial Availability of Twice-Yearly …  -  Feb 17, 2005
17 /PRNewswire-FirstCall/ -- The sanofi-aventis Group announced today the commercial availability in the United States of ELIGARD 45 mg (leuprolide acetate ... RedOrbit

Press Release: Leuprolide Acetate Stabilizes Cognitive and Functional...  -  May 16, 2006
Leuprolide Acetate Stabilizes Cognitive and Functional Decline in Women With Alzheimer's Disease, Study Shows. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

… Reproduction; Cetrorelix and leuprolide acetate comparably inhibit...  -  Mar 21, 2005
2005 MAR 21 - (NewsRx.com) -- Data from an open label, randomized, multicenter study indicate that cetrorelix, a luteinizing hormone-releasing hormone ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones

Success for prostate cancer drug  -  Dec 5, 2008
...men found that those who took degarelix also experienced much larger falls in their prostate-specific antigen levels than those treated with leuprolide. ... Pharmacy Europe

Press Release: Marketing of Viadur(R) (leuprolide acetate implant) to...  -  Dec 20, 2007
Marketing of Viadur(R) (leuprolide acetate implant) to Phase Out by April 2008. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

… Reproduction; Cetrorelix and leuprolide acetate comparably inhibit...  -  Mar 25, 2005
2005 MAR 25 - (NewsRx.com) -- Data from an open label, randomized, multicenter study indicate that cetrorelix, a luteinizing hormone-releasing hormone ... Pay-Per-View - Drug Week - Factiva, from Dow Jones

Leuprolide acetate may delay Alzheimer's decline.(Clinical Rounds)  -  Oct 1, 2006
MADRID -- Leuprolide acetate may help forestall functional decline in patients with mild to moderate Alzheimer's disease, Christopher W. Gregory, Ph.D., ... Free with registration - Family Practice News - AccessMyLibrary.com

LPM Group Ltd acquires Temple Services Ltd - Sep 01, 2007 - Deal …  -  Sep 1, 2007
VACC Clostridium Botulinum Infections PC LPM leuprolide Endometriosis PC LPE Paclitaxel…DOR Radiation Care Product PC LPM leuprolide Prostate Cancer PC LPE… ... Pay-Per-View - deals - Alacra Store

… Reproduction; Cetrorelix and leuprolide acetate comparably inhibit...  -  Mar 26, 2005
They concluded, "Cetrorelix and leuprolide acetate appear to have comparable efficacy and safety, although cetrorelix has the advantage of typically ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

Leuprolide acetate may delay Alzheimer's decline.(Clinical Rounds) | ...  -  Oct 1, 2006
Leuprolide acetate may delay Alzheimer's decline.(Clinical Rounds) ... find Family Practice News articles. MADRID -- Leuprolide acetate may help forestall ... Pay-Per-View - Family Practice News - HighBeam Research

Eligard(R) six-month formulation successfully completes European …  -  Aug 31, 2007
The Atrigel technology allows for sustained delivery of leuprolide acetate ... Sustained levels of leuprolide decrease testosterone levels to suppress tumor ... $4.95 - PR Newswire - ECNext

Drug delivery firm Archimedes makes debut  -  Feb 14, 2005
West Pharma has been developing nasal leuprolide for endometriosis, but Clark noted that there are a number of leuprolide-based treatments on the market, ... In-PharmaTechnologist.com

The Efficacy and Safety of Degarelix: A 12-Month, Comparative, …  -  Dec 12, 2008
To evaluate the efficacy and safety of degarelix, a new gonadotrophin-releasing hormone (GnRH) antagonist (blocker), vs leuprolide for achieving and ... UroToday International Journal

… Achieve Castration Levels in Patients Using Leuprolide Acetate in...  -  Jan 2, 2006
40 patients treated with a 3-monthly formulation of leuprolide acetate and ... Four patients (10%) treated with leuprolide acetate failed to reach the ... UroToday International Journal

Prostate Cancer Drug Reduces Testosterone Levels In As Little As...  -  Dec 17, 2008
In contrast, median testosterone levels in the leuprolide group had increased by 65 per cent by ... The figure for the leuprolide group was 96.4 per cent. ... sciencedaily.com

Article: Ablation device may not require leuprolide step.(Gynecology)...  -  Feb 15, 2005
Ablation device may not require leuprolide step.(Gynecology) ... find OB GYN News articles. SANTA FE, NM -- Although the manufacturer of the Hydro ... Pay-Per-View - OB GYN News - HighBeam Research

Leuprolide acetate seems to forestall Alzheimer's decline.(Geriatric ...  -  Oct 1, 2006
Leuprolide acetate seems to forestall Alzheimer's decline.(Geriatric Psychiatry) ... find Clinical Psychiatry News articles. MADRID -- Leuprolide acetate ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research

… Disease; Trial enrollment completed for DURIN-based leuprolide...  -  Mar 3, 2005
Voyager Pharmaceutical owns a broad-based patent covering the use of leuprolide acetate and other compounds for the treatment of Alzheimer disease. ... Pay-Per-View - Women's Health Weekly - Factiva, from Dow Jones

Leuprolide acetate may forestall decline in AD.(Neurology) | Article...  -  Nov 1, 2006
Leuprolide acetate may forestall decline in AD.(Neurology) ... find Internal Medicine News articles. MADRID -- Leuprolide acetate may help forestall ... Pay-Per-View - Internal Medicine News - HighBeam Research

Alzheimer Disease; Company announces acceptance of DURIN IND …  -  Jan 23, 2005
..."The launch of this study using our unique dose of DURIN-leuprolide acetate optimized for the treatment of Alzheimer disease is an exciting event for ... Pay-Per-View - Medical Devices & Surgical Technology... - Factiva, from Dow Jones

Leuprolide acetate may forestall decline in AD.(Neurology)  -  Nov 1, 2006
MADRID -- Leuprolide acetate may help forestall functional decline in patients with mild to moderate Alzheimer's disease, Christopher W. Gregory, Ph.D., ... $4.95 - Internal Medicine News - ECNext

Voyager Pharmaceutical Corporation Withdraws Initial Public Offering  -  Dec 14, 2005
Voyager's most advanced product candidate is Memryte, a proprietary, small, biodegradable implant that is comprised of leuprolide acetate and a polymer that ... carolinanewswire.com

… of 1-Month and 3-Month Depot Leuprolide Regimens in Central …  -  Jan 19, 2006
Background: Dosing of monthly depot leuprolide (DL) in central precocious puberty (CPP) varies considerably. US practitioners use 7.5-15 mg, ... Journal of Clinical Endocrinology and...

Alzheimer's Patients May Get Skin Patch  -  Jul 19, 2006
Doctors noticed that some men with both Alzheimer's and prostate cancer seemed to fare better cognitively while taking leuprolide. If the effect was real, ... FOXNews

Alzheimer Disease; Study shows leuprolide acetate stabilizes cognitive...  -  Jun 14, 2006
2006 JUN 14 - (NewsRx.com) -- Leuprolide acetate, when used in conjunction with standard Alzheimer therapy, was shown to stabilize the cognitive and ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

FDA Approves Degarelix For Advanced Prostate Cancer Treatment  -  Dec 25, 2008
Phase III studies showed that degarelix is at least as effective as leuprolide (Lupron Depot) in sustaining castrate levels or lower of testosterone, ... emaxhealth.com

QLT cancer drug approved in Germany  -  Dec 1, 2006
Eligard incorporates a luteinizing hormone-releasing hormone agonist, or LHRH agonist, known as leuprolide acetate with QLT's proprietary Atrigel Delivery ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones

Senior Health Report -- Health News for Seniors About Alzheimer's  -  May 15, 2006
Leuprolide acetate, when used in conjunction acetylcholinesterase inhibitors ... Leuprolide acetate, a luteinizing hormone-releasing hormone (LHRH) agonist, ... Senior Health Report

Voyager Pharmaceutical Corporation Announces the Formation of its …  -  Jul 13, 2006
The active ingredient in VP4896, leuprolide acetate, has been used safely for more than 20 years as a treatment for prostate cancer. ... Free with registration - PR Newswire - AccessMyLibrary.com

Leuprolide acetate suppresses pedophilic urges and arousability.(clini...  -  Dec 1, 2005
Traditional treatment of pedophilia has focused on cognitive-behavioral psychotherapy alone and, more recently, cognitive-behavioral psychotherapy combined ... $4.95 - Archives of Sexual Behavior - ECNext

… completes second phase 2 study of leuprolide acetate for treating ...  -  May 31, 2006
The active ingredient in VP4896, leuprolide acetate, has been used safely for over 20 years as a treatment for prostate cancer. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Does Lupron Dosage Make a Difference in Outcome when Treating …  -  Mar 1, 2006
Leuprolide acetate in its depot form is the most frequently used preparation ... Because others have shown that 11.25 mg depot leuprolide every 3 months can ... Journal of Clinical Endocrinology and...

Joseph DeVeaugh-Geiss, MD, expands role as Interim Chief Medical …  -  Jan 16, 2006
Voyager's most advanced product candidate is Memryte, a proprietary, small, biodegradable implant that is comprised of leuprolide acetate and a polymer, ... carolinanewswire.com

Prostate Cancer Drug Reduces Testosterone Levels In As Little As...  -  Dec 9, 2008
In contrast, median testosterone levels in the leuprolide group had increased by 65% by day three, ... The figure for the leuprolide group was 96.4%. ... Medical News Today - Medical News Today (press release)

Article: LLNS.(AGENCIES)(Susan Flinn hired at Lyons/Lavey/Nickel/Swift...  -  Apr 1, 2007
Article: LUPRON DEPOT 3.75 mg (LEUPROLIDE ACETATE FOR DEPOT ... ... TM) is now available for use with Lupron Depot(R) (leuprolide acetate for depot ... to ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Prostate Cancer; Injectable hormonal therapy for advanced prostate …  -  Mar 15, 2005
2005 MAR 15 - (NewsRx.com) -- The sanofi-aventis Group announced the commercial availability in the United States of ELIGARD 45 mg (leuprolide acetate for ... Pay-Per-View - Cancer Weekly - Factiva, from Dow Jones

Sosei files marketing authorisation application for SOT-375.  -  Feb 28, 2005
SOT-375 is an injectable formulation of leuprolide acetate designed to deliver 3.75 mg of the drug substance at a controlled rate over 30 days. ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com

German biotechnology &quot;has not learnt lessons&quot;.(MediGene AG …  -  Oct 31, 2005
...and its prostate cancer therapy Eligard (leuprolide acetate) is on the market, making it the first German biotechnology firm in this position, he said. ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Prostate Cancer; Injectable hormonal therapy for advanced prostate …  -  Mar 19, 2005
2005 MAR 19 - (NewsRx.com) -- The sanofi-aventis Group announced the commercial availability in the United States of ELIGARD 45 mg (leuprolide acetate for ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

ì?¸ìŠ?린 저항성 개선, 심혈관계 위험질환 ê°?소  -  Aug 14, 2008
...� 아니� 국내 유�� �체 �료합성으로 만든 조�제 파미레�(iopamidol), 항암제 로�린��(leuprolide acetate) 등 �종 치료제를 �산, 공급하고 있다. ... 쿠키뉴스

Article: [ BIZ BRIEFS ] - Chicago Sun-Times | HighBeam Research -...  -  Aug 19, 2005
Article: LUPRON DEPOT 3.75 mg (LEUPROLIDE ACETATE FOR DEPOT ... PR Newswire; April 4, ... Lupron Depot (leuprolide acetate), a synthetic ... ... Pay-Per-View - Chicago Sun-Times - HighBeam Research

Novel Approach May Offer New Hope to Women With Alzheimer's …  -  Jul 17, 2006
..."Women treated with leuprolide acetate and the current standard of care, ... "Our trial result demonstrates that leuprolide acetate may benefit a spectrum ... Genetic Engineering News - Genetic Engineering News (press release)

Stock Market Update, IPO profiles, Earnings Call Transcripts,...  -  Sep 9, 2005
Administration of leuprolide acetate using the Memryte implant is designed to minimize an initial dosage peak and provide a steady leuprolide acetate level ... 123Jump.com

Iron deficiency in non-dialysis chronic kidney disease  -  Jun 18, 2008
After discontinuation of leuprolide acetate, menorrhagia recurred, as did iron deficiency. ... Two years after discontinuing leuprolide acetate treatment, ... Nature.com

SOUTH CAROLINA DEPARTMENT OF HEALTH AND HUMAN …  -  Nov 29, 2005
NOTE: Leuprolide acetate and Rho(D) immune globulin do not require PA when used ... Upon receipt of a prescription for leuprolide acetate or Rho(D) immune ... Pay-Per-View - US Fed News - Factiva, from Dow Jones

Frenan tratamientos oncológicos por falta de drogas  -  Nov 28, 2008
...provisión de ciertas drogas especiales, como el "Leuprolide" -utilizado para el tratamiento de la patología de la próstata- y el analgésico "Oxicontin". ... Rio Negro On Line

Abbott Reports Strong Fourth-Quarter Results and Record Operating …  -  Jan 24, 2007
...(e) Without the positive impact of exchange of 4.0 percent, leuprolide sales increased 9.6 percent internationally. (f) Without the positive impact of ... Free with registration - PR Newswire - AccessMyLibrary.com

Clark v. Young, No. 06-C-716-C (WDWis. 12/19/2006)  -  Dec 19, 2006
Petitioner's "freedom, sanity-yea, his very life-depends on obtaining leuprolide treatment." In July 2006, petitioner succeeded in obtaining leuprolide. ... $2.95 - U.S. District Court, Western District... - VersusLaw

המכשול ×”×?חרון הוסר: ועדת הסחר הפדרלית ב×?רה"ב ×?ישרה המיזוג ש?  -  Jan 23, 2006
...בנוסף, הסדרי הפצה שהיו ל×?ייווקס לגבי מוצרי×? נוספי×? כמו ×”-calcitiriol, leuprolide clavulante ו-amoxicillin ... ×”×?רץ

Alzheimer's Patients May Get Skin Patch | Article from AP Online | …  -  Jul 19, 2006
...-Leuprolide, an anti-hormone drug currently used to treat prostate cancer ... If the effect was real, it was puzzling: Leuprolide blocks a hormone that in ... Pay-Per-View - Associated Press/AP Online - HighBeam Research

Alzheimer's Patients May Get Skin Patch | Article from AP Online | …  -  Jul 19, 2006
...-Leuprolide, an anti-hormone drug currently used to treat prostate cancer ... If the effect was real, it was puzzling: Leuprolide blocks a hormone that in ... Pay-Per-View - Associated Press/AP Online - HighBeam Research

Article: Alzheimer's Patients May Get Skin Patch - AP Online |...  -  Jul 20, 2006
...-Leuprolide, an anti-hormone drug currently used to treat prostate cancer ... If the effect was real, it was puzzling: Leuprolide blocks a hormone that in ... Pay-Per-View - Associated Press/AP Online - HighBeam Research

Article: Alzheimer's Patients May Get Skin Patch - AP Online |...  -  Jul 19, 2006
...-Leuprolide, an anti-hormone drug currently used to treat prostate cancer ... If the effect was real, it was puzzling: Leuprolide blocks a hormone that in ... Pay-Per-View - Associated Press/AP Online - HighBeam Research

$16 million raised for Alzheimer's drug.  -  Feb 15, 2005
Leuprolide acetate would be Voyager's first drug on the market. ... Investors in Voyager are betting that leuprolide acetate will at least slow the onset of ... Free with registration - News & Observer - AccessMyLibrary.com

Raleigh, NC, drug company start-up sells stock at auction.  -  Oct 24, 2005
The active ingredient in Memryte is leuprolide acetate, a substance that suppresses ... Products containing leuprolide acetate are on the market to treat ... Free with registration - News & Observer - AccessMyLibrary.com

Competitors by Product Report  -  Apr 14, 2007
Abbott Laboratories (ABT) Products:. Lupron/Lupron Depot Series (Leuprolide Acetate). Novartis AG (ADR) (NVS) Products:. Eon Labs Leuprolide Acetate ... $75.00 - Revere Reports - Revere

New treatment for endometriosis pain has bone-loss warning.(Pain …  -  Sep 1, 2005
Those who had been taking leuprolide showed continued bone mineral density losses of 1.3% in the femur and 1.7% in the spine. ... Free with registration - Clinical Psychiatry News - AccessMyLibrary.com

Favorece IMSS medicina japonesa  -  Feb 8, 2008
Desde 2003, el IMSS compraba la dosis de 3.75 ml de Leuprolide, ... En México, la patente de principio activo del Leuprolide expiró desde antes de 2003 y ... Mural - Mural (Suscripción)

Alzheimer Disease; Company announces acceptance of DURIN IND …  -  Jan 18, 2005
..."The launch of this study using our unique dose of DURIN-leuprolide acetate optimized for the treatment of Alzheimer disease is an exciting event for ... Pay-Per-View - Science Letter - Factiva, from Dow Jones

Investor Group acquires a minority stake in Norwood Abbey Ltd - Deal ...  -  Nov 3, 2005
Depot (leuprolide acetate) Endometriosis M Norwood Abbey Ltd TAP Pharmaceutical Products Norwood Abbey Page # of ## #…acetate) Female Sexual Dysfunction M ... Pay-Per-View - deals - Alacra Store

Alzheimer Disease; Company announces acceptance of DURIN IND …  -  Jan 21, 2005
..."The launch of this study using our unique dose of DURIN-leuprolide acetate optimized for the treatment of Alzheimer disease is an exciting event for ... Pay-Per-View - Genomics & Genetics Weekly - Factiva, from Dow Jones

Press Release: DURECT Corporation Announces Completion of Clinical …  -  Jan 28, 2005
DURECT Corporation Announces Completion of Clinical Trial Enrollment for DURIN(TM)-Based Leuprolide Product Candidate. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

Scientist's theory on diseases of aging being put to test.  -  Sep 20, 2005
Leuprolide acetate dramatically lowers levels of luteinizing hormone. The drug also brings down testosterone and estrogen. In its earlier clinical trials, ... Free with registration - Milwaukee Journal Sentinel - AccessMyLibrary.com

Glucose intolerance during hormonal therapy for prostate cancer  -  Oct 19, 2006
11 reported that in a 26-year-old woman with endometriosis and DM, the evening blood glucose levels after leuprolide acetate were higher than those before ... Nature.com

Accueil / Actualités / Sciences / 0812262212 : La FDA autorise...  -  Dec 26, 2008
Degarelix était au moins aussi efficace que leuprolide pour l'obtention et le maintien des niveaux de testostérone aux niveaux de castration. Intelink

Discover What the Future Holds in the Area of Prostate Cancer …  -  Sep 14, 2007
Sanofi-Aventis/Astellas Pharma's Eligard (leuprolide subcutaneous depot) and Bayer Schering Pharma's Viadur (leuprolide subcutaneous implant). ... Genetic Engineering News - Genetic Engineering News (press release)

Voyager Pharmaceutical Corporation Completes Second Phase II Clinical...  -  May 3, 2006
The active ingredient in VP4896, leuprolide acetate, has been used safely for over 20 years as a treatment for prostate cancer. Voyager's Phase III trial ... Free with registration - PR Newswire - AccessMyLibrary.com

… Completion of Clinical Trial Enrollment for DURIN(TM)-Based Leuprol...  -  Jan 28, 2005
Voyager Pharmaceutical owns a broad-based patent covering the use of leuprolide acetate and other compounds for the treatment of Alzheimer's Disease. ... RedOrbit

Voyager Pharmaceutical Corporation Completes Second Phase II Clinical...  -  May 4, 2006
The active ingredient in VP4896, leuprolide acetate, has been used safely for over 20 years as a treatment for prostate cancer. Voyager's Phase III trial ... Medical News Today - Medical News Today (press release)

Case of the month: diagnostics challenges from your case files.( …  -  Jan 1, 2005
Her condition resolved after treatment with leuprolide (Lupron) for ... Her gynecologic exams have been completely normal since the leuprolide treatment. ... Free with registration - JAAPA-Journal of the American Academy... - AccessMyLibrary.com

GnRH agonist may curb ovarian failure in lupus.(Obstetrics)  -  Mar 1, 2005
Among the 20 patients treated with leuprolide acetate in depot suspension (Lupron, 3.75 mg a month), only 1 developed ovarian failure at the end of 3 years, ... Free with registration - OB GYN News - AccessMyLibrary.com

Sexual Offenders With Mental Illness: Special Considerations for a …  -  Sep 1, 2007
Androgen reduction therapy with depot-leuprolide acetate is being used in other ... (The prescription of SSRIs and depot-leuprolide acetate for the ... Psychiatric Times

Abbott Reports 15.5 Percent Sales Increase in the Fourth Quarter;...  -  Jan 18, 2005
...(d) Without the positive impact of exchange of 6.6 percent, leuprolide sales increased 1.3 percent internationally. (e) Without the positive impact of ... $4.95 - PR Newswire - ECNext

Abbott Reports Strong Third-Quarter Results, Announces $2.5 Billion …  -  Oct 18, 2006
...(e) Without the positive impact of exchange of 3.2 percent, leuprolide sales increased 0.5 percent internationally. (f) Without the positive impact of ... $4.95 - PR Newswire - ECNext

Article: A case of raging hormones?; UW scientist's theory on...  -  Sep 18, 2005
Leuprolide acetate dramatically lowers levels of luteinizing hormone. The drug also brings down testosterone and estrogen. In its earlier clinical trials, ... Pay-Per-View - Milwaukee Journal Sentinel - HighBeam Research

A case of raging hormones? UW scientist's theory on diseases of aging...  -  Sep 18, 2005
Leuprolide acetate dramatically lowers levels of luteinizing hormone. The drug also brings down testosterone and estrogen. In its earlier clinical trials, ... $2.95 - Milwaukee Journal Sentinel - NewsBank

Article: Correction.(Correction Notice) - OB GYN News | HighBeam …  -  Mar 1, 2005
OB GYN News; May 1, 2005 ; 700+ words ... ... which contains 104 mg medroxyprogesterone acetate, treats endometriosis pain as effectively as leuprolide ... Pay-Per-View - OB GYN News - HighBeam Research

Androgen deficit linked to QT prolongation in men.(Men's Health)(Brief...  -  Mar 15, 2005
In the second study, abarelix was compared with leuprolide, and in the third study, abarelix was compared with leuprolide plus bicalutamide. ... Pay-Per-View - Family Practice News - HighBeam Research

Ovarian Hyperstimulation Syndrome; Studies from National Institutes...  -  Dec 11, 2006
GnRH-antagonist (ganirelix acetate) treatment was started and leuprolide acetate discontinued in women who failed to respond to a reduction in gonadotrophin ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones

Article: Depot drug looks safe, helpful for endometriosis. - Internal...  -  Feb 1, 2005
Women taking DMPA-SC and those taking leuprolide experienced substantial improvements in their pelvic pain, both at the end of treatment and 12 months later ... Pay-Per-View - Internal Medicine News - HighBeam Research

Complementary and Alternative Medicine and Prostate Cancer  -  Mar 1, 2007
The remaining participants were treated with leuprolide (n = 1, 7%), external beam radiation therapy (n = 1, 7%), radiation seeds and leuprolide (n = 1, ... Free with registration - Oncology Nursing Forum - AccessMyLibrary.com

Brand Names/Synonyms:
Leuprolide is also known by the following brand names and/or synonymsEligard; Eligard (Atrix Labs/QLT Inc)

Drug Category:
Leuprolide is categorized under the following by the FDA: Antineoplastic Agents; Anti-Estrogen Agents

Dosage Forms:
Not Available

Absorption:
Not Available

Interactions:
Not Available



Chemical IUPAC Name:
5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy